CN102600276A - 一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 - Google Patents
一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 Download PDFInfo
- Publication number
- CN102600276A CN102600276A CN2012101222274A CN201210122227A CN102600276A CN 102600276 A CN102600276 A CN 102600276A CN 2012101222274 A CN2012101222274 A CN 2012101222274A CN 201210122227 A CN201210122227 A CN 201210122227A CN 102600276 A CN102600276 A CN 102600276A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- escherichia coli
- medicine compound
- drug resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 24
- 150000001875 compounds Chemical class 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 206010059866 Drug resistance Diseases 0.000 title abstract description 34
- 241000283690 Bos taurus Species 0.000 claims abstract description 11
- 241001494479 Pecora Species 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000010231 banlangen Substances 0.000 claims description 10
- 239000003613 bile acid Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 7
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims description 5
- 241000245240 Lonicera Species 0.000 claims description 5
- 241000207929 Scutellaria Species 0.000 claims description 5
- 238000003828 vacuum filtration Methods 0.000 claims description 5
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 5
- 230000003313 weakening effect Effects 0.000 abstract description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 240000008537 Burchellia bubalina Species 0.000 abstract 1
- 235000004415 Burchellia bubalina Nutrition 0.000 abstract 1
- 239000004380 Cholic acid Substances 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract 1
- 229960002471 cholic acid Drugs 0.000 abstract 1
- 235000019416 cholic acid Nutrition 0.000 abstract 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 19
- 229940079593 drug Drugs 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 239000008139 complexing agent Substances 0.000 description 11
- 230000003115 biocidal effect Effects 0.000 description 9
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 8
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 230000008030 elimination Effects 0.000 description 6
- 238000003379 elimination reaction Methods 0.000 description 6
- 229940098166 bactrim Drugs 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 229940097572 chloromycetin Drugs 0.000 description 5
- 239000012531 culture fluid Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 5
- 241000157835 Gardenia Species 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
- 229960004821 amikacin Drugs 0.000 description 4
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 4
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 description 4
- 229960002682 cefoxitin Drugs 0.000 description 4
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 description 4
- 229960000484 ceftazidime Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229960003405 ciprofloxacin Drugs 0.000 description 4
- 229960003276 erythromycin Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 4
- 229960001180 norfloxacin Drugs 0.000 description 4
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
- 229960000707 tobramycin Drugs 0.000 description 4
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 4
- 241001570521 Lonicera periclymenum Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010093965 Polymyxin B Proteins 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229920000024 polymyxin B Polymers 0.000 description 3
- 229960005266 polymyxin b Drugs 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000740455 Klebsiella pneumoniae Metallo-beta-lactamase type 2 Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210122227.4A CN102600276B (zh) | 2012-04-24 | 2012-04-24 | 一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210122227.4A CN102600276B (zh) | 2012-04-24 | 2012-04-24 | 一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102600276A true CN102600276A (zh) | 2012-07-25 |
CN102600276B CN102600276B (zh) | 2014-03-12 |
Family
ID=46518295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210122227.4A Withdrawn - After Issue CN102600276B (zh) | 2012-04-24 | 2012-04-24 | 一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102600276B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102973806A (zh) * | 2012-12-06 | 2013-03-20 | 上海中医药大学 | 一种中药组合物及其制备方法和用途 |
CN104383048A (zh) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | 栀子提取物在制备抗含ndm-1耐药基因大肠杆菌药物中的应用 |
CN104383047A (zh) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | 栀子提取物在制备抗鲍曼不动杆菌药物中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1401369A (zh) * | 2002-09-27 | 2003-03-12 | 长春市动物药厂 | 治疗畜禽传染病的抗病毒抗菌消炎的中兽药针剂 |
CN101024024A (zh) * | 2006-02-18 | 2007-08-29 | 何顺生 | 一种抗菌、排毒兽药 |
CN101601754A (zh) * | 2008-06-11 | 2009-12-16 | 上海玉森新药开发有限公司 | 一种清开灵软胶囊的制备方法 |
KR20110024315A (ko) * | 2009-09-02 | 2011-03-09 | 주식회사 셀루스 | 천연 한방원료를 이용한 천연 항균 조성물 |
-
2012
- 2012-04-24 CN CN201210122227.4A patent/CN102600276B/zh not_active Withdrawn - After Issue
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1401369A (zh) * | 2002-09-27 | 2003-03-12 | 长春市动物药厂 | 治疗畜禽传染病的抗病毒抗菌消炎的中兽药针剂 |
CN101024024A (zh) * | 2006-02-18 | 2007-08-29 | 何顺生 | 一种抗菌、排毒兽药 |
CN101601754A (zh) * | 2008-06-11 | 2009-12-16 | 上海玉森新药开发有限公司 | 一种清开灵软胶囊的制备方法 |
KR20110024315A (ko) * | 2009-09-02 | 2011-03-09 | 주식회사 셀루스 | 천연 한방원료를 이용한 천연 항균 조성물 |
Non-Patent Citations (2)
Title |
---|
CHEN QUN,等: "Experimental study of eliminating action of Baicalin and Rhizoma Coptidis on R plasmid of E. coli", 《JOURNAL OF GUAN GDON GMEDICAL COLLEGE》 * |
王静: "中药逆转细菌耐药的研究进展", 《临床和实验医学杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102973806A (zh) * | 2012-12-06 | 2013-03-20 | 上海中医药大学 | 一种中药组合物及其制备方法和用途 |
CN104383048A (zh) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | 栀子提取物在制备抗含ndm-1耐药基因大肠杆菌药物中的应用 |
CN104383047A (zh) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | 栀子提取物在制备抗鲍曼不动杆菌药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102600276B (zh) | 2014-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107927330B (zh) | 一种治疗鱼类肠炎的中草药饲料添加剂 | |
Ngoci et al. | Screening for antimicrobial activity of Cissampelos pareira L. methanol root extract | |
CN103239544A (zh) | 一种渔用中西复方药物组合物及其预混料、配合料和应用 | |
CN102600276B (zh) | 一种能消除大肠杆菌耐药性的中药复方及其制备方法和应用 | |
Amabye et al. | Phytochemical and antimicrobial potentials leaves extract of Eucalyptus Globulus oil from Maichew Tigray Ethiopia | |
CN101933966B (zh) | 板蓝根活性部位组合物及其制备方法及应用 | |
Arekemase et al. | Assessment of Bitter leaf (Vernonia amygdalina) on some selected pathogenic microorganisms from University of Ilorin Teaching Hospital | |
CN105168667A (zh) | 中草药在延缓细菌耐药性中的应用 | |
CN105055539B (zh) | 具有抗菌作用的中草药提取物及其制备方法 | |
CN101612204B (zh) | 猪链球菌耐药抑制剂 | |
CN106177221A (zh) | 一种用于治疗猪大肠杆菌性腹泻的中药组合物及其制备方法 | |
Imam et al. | Anti‐Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis | |
CN113842425A (zh) | 一种具有抗多药耐药菌活性的重楼总皂苷提取物及其制备方法和应用 | |
CN103040897B (zh) | 清开灵活性组分板蓝根提取物在制备抗多重耐药菌药物中的应用 | |
CN101940698B (zh) | 一种用于消除淋病奈瑟菌耐药质粒的药物组合物及其制备方法 | |
KR101968134B1 (ko) | 갯지렁이를 이용한 항균성 조성물 제조방법 | |
CN106138054A (zh) | 白屈菜红碱在治疗禽耐药性大肠杆菌病上的应用 | |
CN103690544A (zh) | 头孢喹肟原料及其制剂在制备治疗禽抗菌药物中的应用 | |
CN104306629B (zh) | 一种抗鸡大肠杆菌病的中药组合物及其制备方法 | |
CN110302219B (zh) | 土荆皮提取物在制备抗耐药鲍曼不动杆菌药物中的应用 | |
Bakrin et al. | Antibacterial Activity of extract Brown Marine Algae, Species Padina Australis Hauck from Coastal Area of Port dickson, Malaysia | |
CN115721677B (zh) | 用于防治犊牛细菌性腹泻的中药组合物及其制备方法和应用 | |
CN108992478A (zh) | 楤木提取物在制备药物中的应用 | |
CN107158052A (zh) | 地稔提取物在制备药物中的应用 | |
CN106692329A (zh) | 一种消炎杀菌中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201211 Address after: No.4, Lane 23, shengjiachang, Jingjiang City, Taizhou City, Jiangsu Province Patentee after: Jingjiang Jiangchen Electric Co.,Ltd. Address before: No. 99 Jiangning Road, Nanjing District hirokage 210000 cities in Jiangsu Province Patentee before: JINLING INSTITUTE OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220523 Address after: 214500 No. 28, Yingbin East Road, Jingjiang City, Taizhou City, Jiangsu Province Patentee after: Jiangsu Huarong Investment Development Co.,Ltd. Address before: No.4, Lane 23, shengjiachang, Jingjiang City, Taizhou City, Jiangsu Province Patentee before: Jingjiang Jiangchen Electric Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230411 Address after: 214500 No. 28, Yingbin East Road, Jingjiang City, Taizhou City, Jiangsu Province Patentee after: Jingjiang City Chengzhong Village Investment and Construction Co.,Ltd. Address before: 214500 No. 28, Yingbin East Road, Jingjiang City, Taizhou City, Jiangsu Province Patentee before: Jiangsu Huarong Investment Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
AV01 | Patent right actively abandoned |
Granted publication date: 20140312 Effective date of abandoning: 20231121 |
|
AV01 | Patent right actively abandoned |
Granted publication date: 20140312 Effective date of abandoning: 20231121 |
|
AV01 | Patent right actively abandoned | ||
AV01 | Patent right actively abandoned |